USA Recombinant DNA Technology Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Recombinant DNA Technology market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Recombinant DNA Technology market. Detailed analysis of key players, along with key growth strategies adopted by Recombinant DNA Technology industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Novo Nordisk

    • Sanofi

    • GlaxoSmithKline

    • Amgen

    • GenScript

    • Pfizer Inc

    • Novartis

    • New England Biolabs

    • Eli Lilly and Company

    • Monsanto Company

    • Cibus

    • Roche

    • Horizon Discovery Group

    • Biogen

    • Profacgen

    • Merck KGaA

    • Biocon

    By Type:

    • Therapeutic Agent

    • Vaccine

    • Biotech Crops

    • Specialty Chemicals

    By End-User:

    • Biotechnology and Pharmaceutical Companies

    • Academic & Government Research Institutes

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Recombinant DNA Technology Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Recombinant DNA Technology Market Size and Growth Rate of Therapeutic Agent from 2016 to 2027

      • 1.3.2 USA Recombinant DNA Technology Market Size and Growth Rate of Vaccine from 2016 to 2027

      • 1.3.3 USA Recombinant DNA Technology Market Size and Growth Rate of Biotech Crops from 2016 to 2027

      • 1.3.4 USA Recombinant DNA Technology Market Size and Growth Rate of Specialty Chemicals from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Recombinant DNA Technology Market Size and Growth Rate of Biotechnology and Pharmaceutical Companies from 2016 to 2027

      • 1.4.2 USA Recombinant DNA Technology Market Size and Growth Rate of Academic & Government Research Institutes from 2016 to 2027

      • 1.4.3 USA Recombinant DNA Technology Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Recombinant DNA Technology Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Recombinant DNA Technology Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Recombinant DNA Technology Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Recombinant DNA Technology Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Recombinant DNA Technology Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Recombinant DNA Technology by Major Types

      • 3.4.1 Market Size and Growth Rate of Therapeutic Agent

      • 3.4.2 Market Size and Growth Rate of Vaccine

      • 3.4.3 Market Size and Growth Rate of Biotech Crops

      • 3.4.4 Market Size and Growth Rate of Specialty Chemicals

    4 Segmentation of Recombinant DNA Technology Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Recombinant DNA Technology by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Recombinant DNA Technology in Biotechnology and Pharmaceutical Companies

      • 4.4.2 Market Size and Growth Rate of Recombinant DNA Technology in Academic & Government Research Institutes

      • 4.4.3 Market Size and Growth Rate of Recombinant DNA Technology in Others

    5 Market Analysis by Regions

    • 5.1 USA Recombinant DNA Technology Production Analysis by Regions

    • 5.2 USA Recombinant DNA Technology Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Recombinant DNA Technology Landscape Analysis

    • 6.1 West USA Recombinant DNA Technology Landscape Analysis by Major Types

    • 6.2 West USA Recombinant DNA Technology Landscape Analysis by Major End-Users

    7 South USA Recombinant DNA Technology Landscape Analysis

    • 7.1 South USA Recombinant DNA Technology Landscape Analysis by Major Types

    • 7.2 South USA Recombinant DNA Technology Landscape Analysis by Major End-Users

    8 Middle West USA Recombinant DNA Technology Landscape Analysis

    • 8.1 Middle West USA Recombinant DNA Technology Landscape Analysis by Major Types

    • 8.2 Middle West USA Recombinant DNA Technology Landscape Analysis by Major End-Users

    9 Northeast USA Recombinant DNA Technology Landscape Analysis

    • 9.1 Northeast USA Recombinant DNA Technology Landscape Analysis by Major Types

    • 9.2 Northeast USA Recombinant DNA Technology Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Novo Nordisk

        • 10.1.1 Novo Nordisk Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Sanofi

        • 10.2.1 Sanofi Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 GlaxoSmithKline

        • 10.3.1 GlaxoSmithKline Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Amgen

        • 10.4.1 Amgen Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 GenScript

        • 10.5.1 GenScript Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Pfizer Inc

        • 10.6.1 Pfizer Inc Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Novartis

        • 10.7.1 Novartis Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 New England Biolabs

        • 10.8.1 New England Biolabs Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Eli Lilly and Company

        • 10.9.1 Eli Lilly and Company Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Monsanto Company

        • 10.10.1 Monsanto Company Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Cibus

        • 10.11.1 Cibus Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Roche

        • 10.12.1 Roche Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Horizon Discovery Group

        • 10.13.1 Horizon Discovery Group Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

      • 10.14 Biogen

        • 10.14.1 Biogen Company Profile and Recent Development

        • 10.14.2 Market Performance

        • 10.14.3 Product and Service Introduction

      • 10.15 Profacgen

        • 10.15.1 Profacgen Company Profile and Recent Development

        • 10.15.2 Market Performance

        • 10.15.3 Product and Service Introduction

      • 10.16 Merck KGaA

        • 10.16.1 Merck KGaA Company Profile and Recent Development

        • 10.16.2 Market Performance

        • 10.16.3 Product and Service Introduction

      • 10.17 Biocon

        • 10.17.1 Biocon Company Profile and Recent Development

        • 10.17.2 Market Performance

        • 10.17.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Recombinant DNA Technology Market Size and Growth Rate of Therapeutic Agent from 2016 to 2027

    • Figure USA Recombinant DNA Technology Market Size and Growth Rate of Vaccine from 2016 to 2027

    • Figure USA Recombinant DNA Technology Market Size and Growth Rate of Biotech Crops from 2016 to 2027

    • Figure USA Recombinant DNA Technology Market Size and Growth Rate of Specialty Chemicals from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Recombinant DNA Technology Market Size and Growth Rate of Biotechnology and Pharmaceutical Companies from 2016 to 2027

    • Figure USA Recombinant DNA Technology Market Size and Growth Rate of Academic & Government Research Institutes from 2016 to 2027

    • Figure USA Recombinant DNA Technology Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Recombinant DNA Technology Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Recombinant DNA Technology Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Recombinant DNA Technology Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Recombinant DNA Technology Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Recombinant DNA Technology Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Recombinant DNA Technology

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Recombinant DNA Technology by Different Types from 2016 to 2027

    • Table Consumption Share of Recombinant DNA Technology by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Therapeutic Agent

    • Figure Market Size and Growth Rate of Vaccine

    • Figure Market Size and Growth Rate of Biotech Crops

    • Figure Market Size and Growth Rate of Specialty Chemicals

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Recombinant DNA Technology by Different End-Users from 2016 to 2027

    • Table Consumption Share of Recombinant DNA Technology by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Biotechnology and Pharmaceutical Companies

    • Figure Market Size and Growth Rate of Academic & Government Research Institutes

    • Figure Market Size and Growth Rate of Others

    • Table USA Recombinant DNA Technology Production by Regions

    • Table USA Recombinant DNA Technology Production Share by Regions

    • Figure USA Recombinant DNA Technology Production Share by Regions in 2016

    • Figure USA Recombinant DNA Technology Production Share by Regions in 2021

    • Figure USA Recombinant DNA Technology Production Share by Regions in 2027

    • Table USA Recombinant DNA Technology Consumption by Regions

    • Table USA Recombinant DNA Technology Consumption Share by Regions

    • Figure USA Recombinant DNA Technology Consumption Share by Regions in 2016

    • Figure USA Recombinant DNA Technology Consumption Share by Regions in 2021

    • Figure USA Recombinant DNA Technology Consumption Share by Regions in 2027

    • Table West USA Recombinant DNA Technology Consumption by Types from 2016 to 2027

    • Table West USA Recombinant DNA Technology Consumption Share by Types from 2016 to 2027

    • Figure West USA Recombinant DNA Technology Consumption Share by Types in 2016

    • Figure West USA Recombinant DNA Technology Consumption Share by Types in 2021

    • Figure West USA Recombinant DNA Technology Consumption Share by Types in 2027

    • Table West USA Recombinant DNA Technology Consumption by End-Users from 2016 to 2027

    • Table West USA Recombinant DNA Technology Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Recombinant DNA Technology Consumption Share by End-Users in 2016

    • Figure West USA Recombinant DNA Technology Consumption Share by End-Users in 2021

    • Figure West USA Recombinant DNA Technology Consumption Share by End-Users in 2027

    • Table South USA Recombinant DNA Technology Consumption by Types from 2016 to 2027

    • Table South USA Recombinant DNA Technology Consumption Share by Types from 2016 to 2027

    • Figure South USA Recombinant DNA Technology Consumption Share by Types in 2016

    • Figure South USA Recombinant DNA Technology Consumption Share by Types in 2021

    • Figure South USA Recombinant DNA Technology Consumption Share by Types in 2027

    • Table South USA Recombinant DNA Technology Consumption by End-Users from 2016 to 2027

    • Table South USA Recombinant DNA Technology Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Recombinant DNA Technology Consumption Share by End-Users in 2016

    • Figure South USA Recombinant DNA Technology Consumption Share by End-Users in 2021

    • Figure South USA Recombinant DNA Technology Consumption Share by End-Users in 2027

    • Table Middle West USA Recombinant DNA Technology Consumption by Types from 2016 to 2027

    • Table Middle West USA Recombinant DNA Technology Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Recombinant DNA Technology Consumption Share by Types in 2016

    • Figure Middle West USA Recombinant DNA Technology Consumption Share by Types in 2021

    • Figure Middle West USA Recombinant DNA Technology Consumption Share by Types in 2027

    • Table Middle West USA Recombinant DNA Technology Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Recombinant DNA Technology Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Recombinant DNA Technology Consumption Share by End-Users in 2016

    • Figure Middle West USA Recombinant DNA Technology Consumption Share by End-Users in 2021

    • Figure Middle West USA Recombinant DNA Technology Consumption Share by End-Users in 2027

    • Table Northeast USA Recombinant DNA Technology Consumption by Types from 2016 to 2027

    • Table Northeast USA Recombinant DNA Technology Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Recombinant DNA Technology Consumption Share by Types in 2016

    • Figure Northeast USA Recombinant DNA Technology Consumption Share by Types in 2021

    • Figure Northeast USA Recombinant DNA Technology Consumption Share by Types in 2027

    • Table Northeast USA Recombinant DNA Technology Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Recombinant DNA Technology Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Recombinant DNA Technology Consumption Share by End-Users in 2016

    • Figure Northeast USA Recombinant DNA Technology Consumption Share by End-Users in 2021

    • Figure Northeast USA Recombinant DNA Technology Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of GenScript

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GenScript

    • Figure Sales and Growth Rate Analysis of GenScript

    • Figure Revenue and Market Share Analysis of GenScript

    • Table Product and Service Introduction of GenScript

    • Table Company Profile and Development Status of Pfizer Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

    • Figure Sales and Growth Rate Analysis of Pfizer Inc

    • Figure Revenue and Market Share Analysis of Pfizer Inc

    • Table Product and Service Introduction of Pfizer Inc

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of New England Biolabs

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of New England Biolabs

    • Figure Sales and Growth Rate Analysis of New England Biolabs

    • Figure Revenue and Market Share Analysis of New England Biolabs

    • Table Product and Service Introduction of New England Biolabs

    • Table Company Profile and Development Status of Eli Lilly and Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company

    • Figure Sales and Growth Rate Analysis of Eli Lilly and Company

    • Figure Revenue and Market Share Analysis of Eli Lilly and Company

    • Table Product and Service Introduction of Eli Lilly and Company

    • Table Company Profile and Development Status of Monsanto Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Monsanto Company

    • Figure Sales and Growth Rate Analysis of Monsanto Company

    • Figure Revenue and Market Share Analysis of Monsanto Company

    • Table Product and Service Introduction of Monsanto Company

    • Table Company Profile and Development Status of Cibus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cibus

    • Figure Sales and Growth Rate Analysis of Cibus

    • Figure Revenue and Market Share Analysis of Cibus

    • Table Product and Service Introduction of Cibus

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Horizon Discovery Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Horizon Discovery Group

    • Figure Sales and Growth Rate Analysis of Horizon Discovery Group

    • Figure Revenue and Market Share Analysis of Horizon Discovery Group

    • Table Product and Service Introduction of Horizon Discovery Group

    • Table Company Profile and Development Status of Biogen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen

    • Figure Sales and Growth Rate Analysis of Biogen

    • Figure Revenue and Market Share Analysis of Biogen

    • Table Product and Service Introduction of Biogen

    • Table Company Profile and Development Status of Profacgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Profacgen

    • Figure Sales and Growth Rate Analysis of Profacgen

    • Figure Revenue and Market Share Analysis of Profacgen

    • Table Product and Service Introduction of Profacgen

    • Table Company Profile and Development Status of Merck KGaA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KGaA

    • Figure Sales and Growth Rate Analysis of Merck KGaA

    • Figure Revenue and Market Share Analysis of Merck KGaA

    • Table Product and Service Introduction of Merck KGaA

    • Table Company Profile and Development Status of Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.